FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:516 August 2, 2007 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

By Jeremy A. Greene. 318 pp., illustrated. Baltimore, Johns Hopkins University Press, 2007. $49.95. ISBN 978-0-8018-8477-1.

At the dawn of the era of personalized medicine, we are poised to understand how patterns of genes and proteins can influence the risk that a disease will develop in an asymptomatic person. We will determine the risk by calculating risk scores and categorizing patients on the basis of those scores. The idea of quantifying risk by means of numeric formulas and then labeling asymptomatic persons as diseased is controversial, but it is not a new concept. In Prescribing by Numbers, Greene reviews the history of the treatment of hypertension, diabetes, and hypercholesterolemia and addresses the idea of treating asymptomatic . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.